URGN - Company ID 0001668243
UroGen Pharma Ltd. has filed 548 public company documents between 2016 and 2026. The most frequent type is insider trade (182 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 4 | Insider trade | 7mo ago2025-12-01 | 2025-11-26 | View filing |
| 4 | Insider trade | 7mo ago2025-12-01 | 2025-11-26 | View filing |
| 4 | Insider trade | 7mo ago2025-12-01 | 2025-11-26 | View filing |
| 4 | Insider trade | 7mo ago2025-12-01 | 2025-11-26 | View filing |
| 4 | Insider trade | 7mo ago2025-12-01 | 2025-11-26 | View filing |
| 4 | Insider trade | 7mo ago2025-11-20 | 2025-11-19 | View filing |
| 144 | Insider sale notice | 7mo ago2025-11-19 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 7mo ago2025-11-14 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 7mo ago2025-11-14 | - | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 7mo ago2025-11-14 | - | View filing |
| 10-Q | Quarterly report | 8mo ago2025-11-06 | 2025-09-30 | View filing |
| 8-K | Major company event | 8mo ago2025-11-06 | 2025-11-06 | View filing |
| S-8 | Employee stock plan | 8mo ago2025-11-06 | - | View filing |
| S-3ASR | S-3ASR | 8mo ago2025-11-06 | - | View filing |
| 4 | Insider trade | 9mo ago2025-10-09 | 2025-10-08 | View filing |
| 144 | Insider sale notice | 10mo ago2025-09-09 | - | View filing |
| 144 | Insider sale notice | 10mo ago2025-09-09 | - | View filing |
| 4 | Insider trade | 10mo ago2025-09-09 | 2025-09-07 | View filing |
| 4 | Insider trade | 10mo ago2025-09-09 | 2025-09-07 | View filing |
| 4 | Insider trade | 10mo ago2025-08-27 | 2025-08-26 | View filing |
| 4 | Insider trade | 10mo ago2025-08-27 | 2025-08-26 | View filing |
| 4 | Insider trade | 10mo ago2025-08-27 | 2025-08-26 | View filing |
| 4 | Insider trade | 10mo ago2025-08-27 | 2025-08-26 | View filing |
| 4 | Insider trade | 10mo ago2025-08-27 | 2025-08-26 | View filing |
| 4 | Insider trade | 10mo ago2025-08-27 | 2025-08-26 | View filing |
| 8-K | Major company event | 10mo ago2025-08-27 | 2025-08-26 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 10mo ago2025-08-14 | - | View filing |
| 4 | Insider trade | 11mo ago2025-08-13 | 2025-08-11 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 11mo ago2025-08-12 | - | View filing |
| 10-Q | Quarterly report | 11mo ago2025-08-07 | 2025-06-30 | View filing |
| 8-K | Major company event | 11mo ago2025-08-07 | 2025-08-07 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-08-05 | - | View filing |
| 4 | Insider trade | 11mo ago2025-07-30 | 2025-07-28 | View filing |
| 4 | Insider trade | 11mo ago2025-07-30 | 2025-07-28 | View filing |
| 4 | Insider trade | 11mo ago2025-07-30 | 2025-07-28 | View filing |
| 144 | Insider sale notice | 11mo ago2025-07-29 | - | View filing |
| 144 | Insider sale notice | 11mo ago2025-07-29 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-07-29 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-07-16 | - | View filing |
| ARS | Annual report to shareholders | 11mo ago2025-07-16 | 2024-12-31 | View filing |
| DEF 14A | Proxy statement | 11mo ago2025-07-15 | 2025-08-11 | View filing |
| 8-K | Major company event | 1y ago2025-07-03 | 2025-06-30 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1y ago2025-06-16 | - | View filing |
| 8-K | Major company event | 1y ago2025-06-13 | 2025-06-12 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1y ago2025-06-13 | - | View filing |
| 4 | Insider trade | 1y ago2025-06-11 | 2025-06-08 | View filing |
| 144 | Insider sale notice | 1y ago2025-06-10 | - | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 1y ago2025-06-09 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-15 | - | View filing |
| 10-Q | Quarterly report | 1y ago2025-05-12 | 2025-03-31 | View filing |